Event Abstract

Biochemical and cellular correlates of embelin against bacterial endotoxin induced airway inflammation

  • 1 Bombay College of Pharmacy, Dept. Pharmacology, India

To investigate mechanism of anti-inflammatory activity of embelin against bacterial endotoxin induced acute lung inflammation.
Embelin was isolated from dried seeds of Embelia ribes. Female Sprague Dawley rats (180-230g) were divided in six groups. Saline (5ml/kg/day,p.o.) Embeline (5,10&20mg/kg/day,p.o.), Roflumilast (1mg/kg/day,p.o.) were administered for four days. Animals were anesthetised with ketamine-xylazine (80:20 mg/kg,i.p.) and administered with sterile solution of LPS (Lipopolysaccharide) intratracheally. After four hours bronchoalveolar lavage was done with icecold phosphate buffer. Bronchoalveolar lavage fluid (BALF) and lung samples were investigated for total cell count, differential cell count and myeloperoxidase, nitrate/nitrite, total Protein, albumin, histopathology respectively.
Data was analysed by GraphPad Prism 5.01 and results were expressed as means ± SEM. P value of <0.05 was considered to be significant.
Saline treated animals showed significant increase in total and differential cell count (p<0.05). Embelin (5,10&20mg/kg) & Roflumilast (1mg/kg) treated animals showed significant decrease in total and differential cell count compared to saline treated animals (p<0.05).
Saline treated animals showed significant increase in myeloperoxidase, nitrosative stress, albumin and total protein in lung samples but embelin (5, 10 & 20mg/kg) and roflumilast (1mg/kg) showed reduction compared to saline treated animals (p<0.05). Mild diffused lesions involving focal interalveolar septal, intraluminal infiltration of neutrophils were observed in embelin (5&10 mg/kg) pretreated while no abnormality was detected in embelin (20 mg/kg) rofelumilast (1mg/kg) pretreated rats.
Embelin showed anti inflammatory and protective effect against LPS induced airway inflammation by reducing nitrosative stress and inhibiting mononucleated cellular infiltration. Further studies on molecular level are in progress.

References

1. Barnes, P.J., K.F. Chung, and C.P. Page, Inflammatory mediators of
asthma: an update. Pharmacological reviews, 1998. 50(4): p. 515-
596.
2. Schwartz, D.A., Does inhalation of endotoxin cause asthma?
American journal of respiratory and critical care medicine, 2001.
163(2): p. 305.
3. Michel, O., Role of lipopolysaccharide (LPS) in asthma and other
pulmonary conditions. Journal of Endotoxin Research, 2003. 9(5): p.
293.
4. Wheeldon, E., et al., Intratracheal aerosolization of endotoxin in the
rat: a model of the adult respiratory distress syndrome (ARDS).
Laboratory animals, 1992. 26(1): p. 29.
5. Khare, C.P., Indian medicinal plants: an illustrated dictionary.
2007: Springer Verlag.
6. Kirtikar, K.R., et al., Indian Medicinal Plants. 1980: Bishen Singh,
Mahendra Pal Singh.
7. Chitra, M., et al., Antitumor, anti-inflammatory and analgesic
property of embelin, a plant product. Chemotherapy, 1994. 40(2): p.
109-113.
8. Mahendran, S., S. Badami, and V. Maithili, Evaluation of
antidiabetic effect of embelin from Embelia ribes in alloxan induced
diabetes in rats. Biomedicine & Preventive Nutrition, 2011. 1(1): p.
25-31.
9. Mahendran, S., et al., Anticonvulsant activity of embelin isolated
from Embelia ribes. Phytomedicine, 2011. 18(2): p. 186-188.
10. Bhandari, U., M.N. Ansari, and F. Islam, Cardioprotective effect of
aqueous extract of Embelia ribes Burm fruits against isoproterenolinduced
myocardial infarction in albino rats. Indian journal of
experimental biology, 2008. 46(1): p. 35.
11. Joshi, R., J. Kamat, and T. Mukherjee, Free radical scavenging
reactions and antioxidant activity of embelin: Biochemical and pulse
radiolytic studies. Chemico-biological interactions, 2007. 167(2): p.
125-134.
12. Nikolovska-Coleska, Z., et al., Discovery of embelin as a cellpermeable,
small-molecular weight inhibitor of XIAP through
structure-based computational screening of a traditional herbal
medicine three-dimensional structure database. Journal of medicinal
chemistry, 2004. 47(10): p. 2430-2440.
13. Spond, J., et al., Comparison of PDE 4 Inhibitors, Rolipram and SB
207499 (ArifloTM, in a Rat Model of Pulmonary Neutrophilia* 1.
Pulmonary Pharmacology & Therapeutics, 2001. 14(2): p. 157-164.
14. Bradley, P.P., R.D. Christensen, and G. Rothstein, Cellular and
extracellular myeloperoxidase in pyogenic inflammation. Blood,
1982. 60(3): p. 618.
15. Leza, J.C., et al., The effects of stress on homeostasis in JCR-LA-cp
rats: the role of nitric oxide. Journal of Pharmacology and
Experimental Therapeutics, 1998. 286(3): p. 1397.
16. Lowry, O., et al., Protein estimation with the Folin phenol reagent. J
Biol Chem, 1951. 193: p. 265-275.
17. Doumas, B. and H. Biggs, Estimation of albumin in serum. Standard
Methods. Clin. Chem, 1972. 7: p. 175-188.
18. O'Byrne, P.M., M.D. Inman, and E. Adelroth, Reassessing the Th2
cytokine basis of asthma. Trends in pharmacological sciences, 2004.
25(5): p. 244-248.
19. Bochner, B.S., Adhesion molecules as therapeutic targets.
Immunology and allergy clinics of North America, 2004. 24(4): p.
615-630.
20. Yang, R.B., et al., Toll-like receptor-2 mediates lipopolysaccharideinduced
cellular signalling. Nature, 1998. 395(6699): p. 284-288.
21. Ohkawara, Y., et al., Human lung mast cells and pulmonary
macrophages produce tumor necrosis factor-alpha in sensitized lung
tissue after IgE receptor triggering. American journal of respiratory
cell and molecular biology, 1992. 7(4): p. 385.
22. Finotto, S., et al., TNF-alpha production by eosinophils in upper
airways inflammation (nasal polyposis). The Journal of
Immunology, 1994. 153(5): p. 2278.
23. Abdelaziz, M., et al., The effect of conditioned medium from
cultured human bronchial epithelial cells on eosinophil and
neutrophil chemotaxis and adherence in vitro. American journal of
respiratory cell and molecular biology, 1995. 13(6): p. 728.
24. Bodey, K., et al., Cytokine profiles of BAL T cells and T cell clones
obtained from human asthmatic airways after local allergen
challenge. Allergy, 1999. 54(10): p. 1083-1093.
25. Kips, J., J. Tavernier, and R. Pauwels, Tumor necrosis factor causes
bronchial hyperresponsiveness in rats. The American review of
respiratory disease, 1992. 145(2 Pt 1): p. 332.
26. Lefort, J., et al., Systemic administration of endotoxin induces
bronchopulmonary hyperreactivity dissociated from TNF- formation
and neutrophil sequestration into the murine lungs. The Journal of
Immunology, 1998. 161(1): p. 474.
27. Cavarra, E., et al., Neutrophil recruitment into the lungs is
associated with increased lung elastase burden, decreased lung
elastin, and emphysema in 1 proteinase inhibitor-deficient mice.
Laboratory investigation, 1996. 75(2): p. 273-280.
28. Corteling, R., D. Wyss, and A. Trifilieff, In vivo models of lung
neutrophil activation. Comparison of mice and hamsters. BMC
pharmacology, 2002. 2(1): p. 1.
29. Asti, C., et al., Lipopolysaccharide-induced Lung Injury in Mice. I.
Concomitant Evaluation of Inflammatory Cells and Haemorrhagic
Lung Damage* 1. Pulmonary Pharmacology & Therapeutics, 2000.
13(2): p. 61-69.
30. Barnes, P.J. and M. Belvisi, Nitric oxide and lung disease. Thorax,
1993. 48(10): p. 1034-1043.
31. Taylor-Robinson, A.W., et al., The role of TH1 and TH2 cells in a
rodent malaria infection. Science, 1993. 260(5116): p. 1931-1934.
32. Colasanti, M., et al., Human ramified microglial cells produce nitric
oxide upon Escherichia coli lipopolysaccharide and tumor necrosis
factor [alpha] stimulation. Neuroscience letters, 1995. 200(2): p.
144-146.
33. Kwak, H.J., et al., Roflumilast inhibits lipopolysaccharide-induced
inflammatory mediators via suppression of nuclear factor-κB, p38
mitogen-activated protein kinase, and c-Jun NH2-terminal kinase
activation. Journal of Pharmacology and Experimental Therapeutics,
2005. 315(3): p. 1188-1195.

Keywords: Bacterial endotoxin, airway inflammation, Embelin, Embelia ribes, LPS

Conference: 15th International Congress of Immunology (ICI), Milan, Italy, 22 Aug - 27 Aug, 2013.

Presentation Type: Abstract

Topic: Translational immunology and immune intervention

Citation: Saraf MN, Shirole R, Badgujar LB and Kshatriya A (2013). Biochemical and cellular correlates of embelin against bacterial endotoxin induced airway inflammation. Front. Immunol. Conference Abstract: 15th International Congress of Immunology (ICI). doi: 10.3389/conf.fimmu.2013.02.00571

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 02 May 2013; Published Online: 22 Aug 2013.

* Correspondence: Dr. Madhusudan N Saraf, Bombay College of Pharmacy, Dept. Pharmacology, Mumbai, Maharashtra, 400098, India, madhusudan.saraf@gmail.com